Integrating the Value of Diagnostic and Prognostic Information With Efficiency Enhancements in Healthcare Systems
Moderator
Belinda A Mohr, PhD, Medtronic, Phoenix, AZ, United States
Speakers
Sudha Kutty, BSc, MBA, LLB, Canada's Drug Agency, Toronto, ON, Canada; Artem T Boltyenkov, MBA, PhD, Siemens Healthcare Diagnostics Inc., Lexington, SC, United States; Vincent De Guire, PhD, CSPQ, DEPD, Maisonneuve-Rosemont hospital, Montreal, QC, Canada
Presentation Documents
The objective of this forum is to explore the intersection of diagnostic and prognostic information with capacity-enhancing innovations in healthcare systems. By combining these two critical areas, we aim to create awareness and facilitate discussions on how effective capacity-enhancing innovations including diagnostics can improve patient pathways, influence treatment outcomes, and ultimately enhance system efficiency. Our approach will particularly focus on the impact of early diagnosis on patient care and healthcare efficiency metrics.
The significance of integrating and valuating diagnostic and prognostic information into healthcare delivery is paramount in contemporary practice. Efficient inclusion of diagnostic and prognostic tools and innovative medical technologies can streamline patient care—from diagnosis through treatment, prognosis and monitoring—significantly impacting efficiency-related key performance indicators. However, the transportability, measurement, and recognition of these efficiency gains by Health Technology Assessment (HTA) bodies, providers, and procurers is often hindered by organizational readiness and sustainability measures in the existing healthcare environment. By examining case studies and expert insights, we will highlight best practices and challenges associated with realizing, assessing, and valuating these benefits.
Our panel will feature the perspectives of stakeholders spanning various sectors of the healthcare ecosystem, including healthcare providers, industry representatives, and HTA bodies. Discussions will address the specific roles of medical devices and diagnostics in optimizing patient pathways, addressing the challenges associated with identifying and measuring relevant efficiency dimensions, and the potential for integrated care approaches. A particular emphasis will be placed on how efficient practices can be achieved through early diagnoses and the restructuring of healthcare professional deployment and how those should be measured and considered in technology assessment to ensure timely adoption and valuation.
Code
033
Topic
Health Service Delivery & Process of Care, Health Technology Assessment, Medical Technologies